Updates on Smoking and Schizophrenia

Jill M. Williams, MD, is Associate Professor of Psychiatry and Director of the Division of Addiction Psychiatry at the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School in New Brunswick. She also holds faculty appointments with the UMDNJ-School of Public Health Tobacco Dependence Program and the Cancer Institute of New Jersey. She received her medical degree from UMDNJ-Robert Wood Johnson Medical School in Piscataway and completed her residency training at Duke University Medical Center in Durham, North Carolina. Dr. Williams also completed a fellowship in Addiction Psychiatry at UMDNJ-Robert Wood Johnson Medical School.

A Diplomate in Psychiatry, Dr. Williams is board-certified by the American Board of Psychiatry and Neurology with Added Qualifications in Addiction Psychiatry. She is a member of the Association for the Treatment of Tobacco Use and Dependence, the American Psychiatric Association, the Society for Research on Nicotine and Tobacco, and the American Association of Community Psychiatrists. She was awarded the Silver Award for the CHOICES (Consumers Helping Others Improve their Condition by Ending Smoking) Program by the American Psychiatric Association Institute of Psychiatric Services in 2009. Dr Williams is the CME Course Director for a two-day training conference for Psychiatrists, Advanced Practice Nurses, and other Mental Health Professionals on Tobacco Dependence Treatment.

Dr. Williams is currently Principal Investigator of a double-blind, placebo-controlled trial of nicotine nasal spray as a smoking cessation aid in schizophrenia. Her publications have appeared in numerous journals including Nicotine and Tobacco Research, the Journal of the American Medical Association, and the Journal of Substance Abuse Treatment.